Google
INMD Stock Analysis — INMODE LTD (Healthcare >> Medical Devices)
INMD FAQ
What is INMD's P/E ratio?
INMODE LTD (INMD) currently trades at a P/E ratio of 9.95.
What is INMD's ROE?
INMODE LTD reports a Return on Equity (ROE) of 13.19%.
What is INMD's dividend yield?
INMODE LTD offers a dividend yield of 0.00%.
What is INMD's Quality Score?
Our AI rates INMD's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy INMD?
Our AI Timing Score for INMD is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does INMD belong to?
INMODE LTD is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange
INMD AI Analysis Summary
Our AI summary for INMD: INMODE LTD (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 9.95, ROE of 13.19%, a dividend yield of 0.00%. Its financial Quality Score stands at 62/100 — mid-range fundamentals relative to the market. The AI Timing Score is 87/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 15.14
Price
0.05
(0.30%)
Day Change
|
|
|---|
INMD, the overall quality is ok ( Quality = 62) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
54% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 85 |
| Magic Formula Rank by ROA |
260
|
| Magic Formula Rank by ROE |
260
|
| Magic Formula Rank by ROIC |
161
|
| Price | 15.14 |
| PBV / Sector |
1.31 / -101.57
GOOD
|
| Earning Per Share | 1.52 |
| PE / Sector |
9.95 / 31.23
GREAT
|
| PEG or PE/Growth / Sector |
-1.77 / 0.40
|
| Average 1M Daily Value |
9.55 M
|
| Average 1W Daily Value |
9.98 M
|
| Timing Factors |
|
57% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
66% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-08-01 08:00:01 |
| Symbol | INMD |
| Name | INMODE LTD |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 57.48 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 867.67 / 20,104.97 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Tavor Building, Yokne'am, Israel, 2069206
Phone: 972 4 909 6313
Website: https://www.inmodemd.com
Employees: 660
Sector: Healthcare >> Medical Devices
Description: InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. In addition, it offers hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. The company was incorporated in 2008 and is headquartered in Yokne'am, Israel.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
